FDA Inspection 1025379 — Dr. Ewa Smukalska
The FDA completed an inspection of Dr. Ewa Smukalska on Aug 18, 2017 in Bydgoszcz. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 18, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bydgoszcz (Poland)
Additional details
Clinical Investigator (CI)